Mark Huckabee
About Mark Huckabee
Mark Huckabee is a Capture Director at DLH Corporation, specializing in systems for cleaning up nuclear waste and bio-terrorism detection. He has extensive experience in technology evaluation for venture capital, government contracts, and consulting across various industries.
Work at DLH Corporation
Mark Huckabee has been serving as Capture Director at DLH Corporation since 2024. His role involves leading initiatives to secure government contracts and manage strategic projects. He operates remotely from Alaska, aligning his work primarily with East Coast US time. Huckabee's extensive experience in capture management and technology evaluation supports DLH's objectives in the government contracting space.
Previous Experience at Leidos
Prior to his current position, Huckabee worked at Leidos for 26 years. He held various roles, including Senior Consultant, System Architect, and Project Manager from 1998 to 2015. He then transitioned to Senior Capture Manager, a role he maintained until 2024. His tenure at Leidos involved consulting across multiple industries, contributing to significant projects and contract acquisitions.
Career at BNFL
Mark Huckabee worked at BNFL as the Chief Information Officer and IT Director of a subsidiary from 1995 to 1998. During his time in Oak Ridge, TN, he focused on the development of systems for cleaning up nuclear waste. This role contributed to his expertise in managing complex technological projects within the nuclear sector.
Education and Expertise
Huckabee studied at Rice University, where he earned a Bachelor of Science degree in Chemical Engineering from 1978 to 1982. His educational background laid the foundation for his technical expertise in various fields, including software development for bio-terrorism detection and data science applications in public health.
Achievements in Government Contracting
Throughout his career, Huckabee has managed teams that secured over a billion dollars in government contracts. His experience includes consulting for venture capital firms to evaluate technology investments and leading data science teams for the CDC, focusing on disease propagation research. He has also presented to high-level government officials, including Congress and the National Academy of Sciences.